A long-lasting implant to help treat opioid addiction
A Long-Acting Bioabsorbable Naltrexone Subcutaneous Implant for Opioid Use Disorder
This study is working on a special implant that slowly releases a medication called Naltrexone to help people with opioid addiction, and it aims to make sure the implant is safe and effective for long-term use.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Drug Delivery Company, LLC, the NIH-funded |
| Lab location | 1 site (Salisbury, United States) |
| Project ID | NIH-11086785 on NIH RePORTER |
What this research studies
This research focuses on developing a bioabsorbable implant that delivers Naltrexone, a medication used to treat opioid use disorder. The project aims to optimize the chemical formulation and design of the implant to ensure it releases the medication effectively while minimizing side effects. The research will involve both laboratory testing and surgical procedures to ensure the implant can be safely and effectively placed in patients. Ultimately, the goal is to provide a long-term solution for individuals struggling with opioid addiction.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with opioid use disorder who are seeking long-term treatment options.
Not a fit: Patients who are not struggling with opioid use disorder or those who are not suitable for surgical implantation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a more effective and convenient treatment option for individuals with opioid use disorder.
How similar studies have performed: Previous research has shown promise in using long-acting formulations for addiction treatment, indicating potential success for this novel approach.
Where this research is happening
Salisbury, United States
- Drug Delivery Company, LLC, the — Salisbury, United States (Active)
Researchers
- Principal investigator: Cohen, Steven M — Drug Delivery Company, LLC, the
- Study coordinator: Cohen, Steven M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.